IsoFlux CTC and Rare Cell Isolation
Transforming cancer diagnosis through non-invasive blood tests
At Fluxion, we’re committed to developing liquid CTC and rare cell isolation and analysis solutions. Our goal is to deliver blood tests that provide an accurate, sensitive cancer molecular profile, leading to better treatment decisions and improved patient outcomes.
Fluxion’s IsoFlux CTC and rare cell solutions are used globally by leading research centers in the development of novel assays for early cancer detection, therapy selection, and patient monitoring.
ISOFLUX SYSTEM: HIGH SENSITIVITY CTC ISOLATION AND ANALYSIS FROM BLOOD SAMPLES
The IsoFlux System combines the power of antibody-based magnetic bead separations with the precision of flow cytometry to deliver unmatched CTC recovery efficiency.